KPV
Symbol Kp · MW 342 Da
Tripeptide derived from α-MSH studied for inflammation and gut healing.
- Discovered
- 1989
- Half-life
- 2-4 hours
- Approval
- Not FDA-approved
Reported effects
- Anti-inflammatory
- Gut barrier support
- Skin healing
Overview
KPV is a short anti-inflammatory peptide made from three amino acids: lysine, proline, and valine. It is derived from alpha-MSH, a hormone involved in immune response and inflammation regulation. KPV is commonly researched for skin inflammation, gut health, immune balance, and irritation control. As a recovery peptide, it is often associated with calming overactive inflammatory responses rather than directly rebuilding tissue. KPV may be used in discussions about skin barrier support, inflammatory bowel research, wound healing, and immune system regulation. Its purpose is to help support a more balanced inflammatory environment in the body.
How it's taken
- Typical Administration
- Topical / Injectable
- Typical Dosage
- No established approved dosage; commonly referenced injectable range is 200–500 mcg daily; topical formulations commonly use low-percentage cosmetic concentrations
- Typical Frequency
- Injectable once or twice daily; topical once or twice daily
Research sources
Source links included from peer-reviewed literature and trusted medical journal records for this peptide.
Interested in KPV?
Enter your email and we'll send you a curated list of vendors we trust for sourcing this peptide.
No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions.